RT Journal Article
SR Electronic
T1 Deconvoluting Virome-Wide Antiviral Antibody Profiling Data
JF bioRxiv
FD Cold Spring Harbor Laboratory
SP 333625
DO 10.1101/333625
A1 Daniel R. Monaco
A1 Sanjay V. Kottapalli
A1 Tiezheng Yuan
A1 Florian P. Breitwieser
A1 Danielle E. Anderson
A1 Limin Wijaya
A1 Kevin Tan
A1 Wan Ni Chia
A1 Kai Kammers
A1 Mario Caturegli
A1 Kathleen Waugh
A1 Marian Rewers
A1 Lin-Fa Wang
A1 H. Benjamin Larman
YR 2018
UL http://biorxiv.org/content/early/2018/05/30/333625.abstract
AB The ability to comprehensively characterize exposures and immune responses to viral infections will be critical to better understanding human health and disease. We previously described the VirScan system, a phage-display based technology for profiling antibody binding to a comprehensive library of peptides designed to represent the human virome. The previous VirScan analytical approach did not fully account for disproportionate representation of viruses in the library or for antibody cross-reactivity among sequences shared by related viruses. Here we present the ‘AntiViral Antibody Response Deconvolution Algorithm’ (‘AVARDA’), a multi-module software package for analyzing VirScan datasets. AVARDA provides a probabilistic assessment of infection at species-level resolution by considering alignment of all library peptides to each other and to all human viruses. We employed AVARDA to analyze VirScan data from a cohort of encephalitis patients with either known viral infections or undiagnosed etiologies. By comparing acute and convalescent sera, AVARDA successfully confirmed or detected antibody responses to human herpesviruses 1, 3, 4, 5, and 6, thereby improving the rate of diagnosing viral encephalitis in this cohort by 62.5%. We further assessed AVARDA’s utility in the setting of an epidemiological study, demonstrating its ability to determine infections acquired in a child followed prospectively from infancy. We consider ways in which AVARDA’s conceptual framework may be further developed in the future and describe how its analyses may be extended beyond investigations of viral infection. AVARDA, in combination with VirScan and other pan-pathogen serological techniques, is likely to find broad utility in the epidemiology and diagnosis of infectious diseases.